Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting
収録刊行物
-
- Lung Cancer
-
Lung Cancer 89 (2), 161-166, 2015-08
Elsevier BV